Abstract
BackgroundElectroacupuncture (EA) is reported to be an effective treatment for obesity, but its mechanism is unclear. This study aimed to investigate the relationship between hypothalamic LKB1-AMPK-ACC signaling and EA.MethodsFifty male Sprague–Dawley rats were divided into two groups fed either chow (chow-fed group) or high-fat diet (HF group). After 4 weeks of feeding, obese rats in the HF group (defined as weighing 20 % or more than rats in the chow-fed group) were randomly allocated into an EA or Diet-induced obesity (DIO) group. The EA group was given EA on bilateral ST25–ST36 for 4 weeks, while the DIO group received no further intervention. Body weight of the chow-fed, DIO, and EA groups were measured weekly. mRNA and protein levels of the hypothalamic LKB1-AMPK-ACC signaling pathway were detected using real-time (RT)-PCR and western blot, respectively.ResultsAfter 4 weeks of EA treatment, the weight growth trend of rats in the EA group was inhibited compared with those in the DIO group. RT-PCR and western blotting showed that EA upregulated the transcription of Adenosine 5′-monophosphate -activated protein kinase α2 (AMPKα2), promoted protein expression of Liver kinase B1 (LKB1) and AMPKα1, and inhibited acetyl-CoA carboxylase (ACC) protein expression in the hypothalamus.ConclusionsThis study suggests that hypothalamic LKB1-AMPK-ACC signaling plays an important role in EA treatment for obesity.
Highlights
Electroacupuncture (EA) is reported to be an effective treatment for obesity, but its mechanism is unclear
We investigated the role of hypothalamic Liver kinase B1 (LKB1)-Adenosine 5′-monophosphate -activated protein kinase (AMPK)-acetyl-CoA carboxylase (ACC) signaling in the obesity pathology and EA treatment mechanism
Our results demonstrate that EA rats had significantly higher protein levels of LKB1 and pAMPKα1 compared with diet-induced obesity (DIO) rats
Summary
Electroacupuncture (EA) is reported to be an effective treatment for obesity, but its mechanism is unclear. Several investigations into curbing the increasing obese population have been conducted, but there are few effective pharmacological treatments. Three drugs have been approved by the US Food and Drug Administration for long-term obesity treatment, namely lorcaserin (Belviq), phentermine plus topiramate (Qsymia), and orlistat (Xenical, Alli) [2]. Acupuncture is one of the most popular alternative therapies, and it has been used to treat obesity for thousands of years. Recent systematic reviews indicate that EA is an effective treatment for obesity [4]. The mechanism of EA on obesity needs further investigation. The possible mechanisms underlying the effect of EA focus on the hypothalamus [5, 6]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.